Skip to Content

Notice

Qualification of Drivers; Exemption Applications; Diabetes Mellitus

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION:

Notice of final disposition.

SUMMARY:

FMCSA confirms its decision to exempt 88 individuals from its rule prohibiting persons with insulin-treated diabetes mellitus (ITDM) from operating commercial motor vehicles (CMVs) in interstate commerce. The exemptions enable these individuals to operate CMVs in interstate commerce.

DATES:

The exemptions were effective on August 19, 2014. The exemptions expire on August 19, 2016.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Elaine M. Papp, R.N., Chief, Medical Programs Division, (202) 366-4001, fmcsamedical@dot.gov, FMCSA, Room W64-224, Department of Transportation, 1200 New Jersey Avenue SE., Washington, DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., Monday through Friday, except Federal holidays.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

I. Electronic Access

You may see all the comments online through the Federal Document Management System (FDMS) at: http://www.regulations.gov.

Docket: For access to the docket to read background documents or comments, go to http://www.regulations.gov and/or Room W12-140 on the ground level of the West Building, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays.

Privacy Act: Anyone may search the electronic form of all comments received into any of DOT's dockets by the name of the individual submitting the comment (or of the person signing the comment, if submitted on behalf of an association, business, labor union, or other entity). You may review DOT's Privacy Act Statement for the Federal Docket Management System (FDMS) published in the Federal Register on January 17, 2008 (73 FR 3316).

II. Background

On July 17, 2014, FMCSA published a notice of receipt of Federal diabetes exemption applications from 88 individuals and requested comments Start Printed Page 56106from the public (79 FR 41723). The public comment period closed on August 18, 2014, and three comments were received.

FMCSA has evaluated the eligibility of the 88 applicants and determined that granting the exemptions to these individuals would achieve a level of safety equivalent to or greater than the level that would be achieved by complying with the current regulation 49 CFR 391.41(b)(3).

III. Diabetes Mellitus and Driving Experience of the Applicants

The Agency established the current requirement for diabetes in 1970 because several risk studies indicated that drivers with diabetes had a higher rate of crash involvement than the general population. The diabetes rule provides that “A person is physically qualified to drive a commercial motor vehicle if that person has no established medical history or clinical diagnosis of diabetes mellitus currently requiring insulin for control” (49 CFR 391.41(b)(3)).

FMCSA established its diabetes exemption program, based on the Agency's July 2000 study entitled “A Report to Congress on the Feasibility of a Program to Qualify Individuals with Insulin-Treated Diabetes Mellitus to Operate in Interstate Commerce as Directed by the Transportation Act for the 21st Century.” The report concluded that a safe and practicable protocol to allow some drivers with ITDM to operate CMVs is feasible. The September 3, 2003 (68 FR 52441), Federal Register notice in conjunction with the November 8, 2005 (70 FR 67777), Federal Register notice provides the current protocol for allowing such drivers to operate CMVs in interstate commerce.

These 88 applicants have had ITDM over a range of 1 to 38 years. These applicants report no severe hypoglycemic reactions resulting in loss of consciousness or seizure, requiring the assistance of another person, or resulting in impaired cognitive function that occurred without warning symptoms, in the past 12 months and no recurrent (2 or more) severe hypoglycemic episodes in the past 5 years. In each case, an endocrinologist verified that the driver has demonstrated a willingness to properly monitor and manage his/her diabetes mellitus, received education related to diabetes management, and is on a stable insulin regimen. These drivers report no other disqualifying conditions, including diabetes-related complications. Each meets the vision requirement at 49 CFR 391.41(b)(10).

The qualifications and medical condition of each applicant were stated and discussed in detail in the July 17, 2014, Federal Register notice and they will not be repeated in this notice.

IV. Discussion of Comments

FMCSA received three comments in this proceeding. The comments are discussed below.

One anonymous commenter explained that all drivers with type 1 and type 2 diabetes spend much time and effort complying with local and state regulations.

Two anonymous commenters are in favor of granting the exemptions to the drivers.

V. Basis for Exemption Determination

Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption from the diabetes requirement in 49 CFR 391.41(b)(3) if the exemption is likely to achieve an equivalent or greater level of safety than would be achieved without the exemption. The exemption allows the applicants to operate CMVs in interstate commerce.

To evaluate the effect of these exemptions on safety, FMCSA considered medical reports about the applicants' ITDM and vision, and reviewed the treating endocrinologists' medical opinion related to the ability of the driver to safely operate a CMV while using insulin.

Consequently, FMCSA finds that in each case exempting these applicants from the diabetes requirement in 49 CFR 391.41(b)(3) is likely to achieve a level of safety equal to that existing without the exemption.

VI. Conditions and Requirements

The terms and conditions of the exemption will be provided to the applicants in the exemption document and they include the following: (1) That each individual submit a quarterly monitoring checklist completed by the treating endocrinologist as well as an annual checklist with a comprehensive medical evaluation; (2) that each individual reports within 2 business days of occurrence, all episodes of severe hypoglycemia, significant complications, or inability to manage diabetes; also, any involvement in an accident or any other adverse event in a CMV or personal vehicle, whether or not it is related to an episode of hypoglycemia; (3) that each individual provide a copy of the ophthalmologist's or optometrist's report to the medical examiner at the time of the annual medical examination; and (4) that each individual provide a copy of the annual medical certification to the employer for retention in the driver's qualification file, or keep a copy in his/her driver's qualification file if he/she is self-employed. The driver must also have a copy of the certification when driving, for presentation to a duly authorized Federal, State, or local enforcement official.

VII. Conclusion

Based upon its evaluation of the 88 exemption applications, FMCSA exempts the following drivers from the diabetes requirement in 49 CFR 391.41(b)(10), subject to the requirements cited above 49 CFR 391.64(b)):

Charles Ackerman Jr. (NJ), William J. Applebee (WI), Matthew D. Barney (IA), Benjamin L. Baxter (MI), Stephen M. Berggren (MN), Robert A. Boyle (ID), Patrick J. Burns (MN), Mathew A. Cardon (AZ), Robert L. Caudill (OH), Vernon R. Cornish (AR), Charles L. Cran (WI), John W. Crook Jr. (IA), Michael A. Dinkel (NJ), William C. Dixon (TX), Donald R. Dunaway (OH), Kevin W. Elder (NC), Michael J. Eldridge, Sr. (IA), Johnathon C. Ely (IN), Kevin D. Erickson (WI), Wayne D. Erickson (MN), Walter C. Evans (CT), Joby E. Foshee, IV (MS), Lawrence H. Fox (NH), Troy C. Frank (NE), Robert T. Frankfruter (CO), Koby L. Garman (PA), Dale A. Godejohn (ND), Robert R. Gonzales (CA), Norman D. Groves (MO), Kenneth F. Gwaltney (IN), Mathew R. Hale (KS), Donald K. Hamilton (FL), John L. Holtzclaw (MO), Christopher H. Horn (NH), Donald L. Howard (TX), Jared E. Hubbard (TX), Roger C. Hulce (UT), Kip J. Kauffman (WI), Christopher J. Kittoe (WI), Joshua L. Kroetch (MN), Wesley S. Langham (IL), Andrew K. Lofton (AL), Salvador Lopez (AZ), Joseph M. Macias (NM), Robert J. Marino (NJ), Kasey L. Martin (TX), David J. McCoy (UT), William E. Medlin (MN), Anthony J. Miller (MN), Charles A. Napoles, Jr. (NJ), Kathryn J. Nelms (KS), Antonio C. Oliveira (PA), Kent E. Oswald (NY), Christopher P. Overton (IL), Ronald E. Patrick (IN), Ronald E. Patterson, Jr. (TN), Stephen J. Pelton (PA), Bryant S. Perry (NC), Kenneth R. Perschon (IL), Joseph R. Polhamus (LA), Brian J. Rajkovich (CA), Joseph E. Resetar (NJ), Donnell T. Rhone (TN), Charles E. Rich (KS), Rodney B. Roberets (MS), Arlan M. Roesler (WI), Mark J. Rone (IL), Ronny J. Sanders (UT), Barry J. Sanderson (MT), Russell E. Shipp (RI), David J. Standley (WA), John J. Steigauf (MN), Berton W. Stroup (PA), Scott W. Stutts (AR), Jason B. Taylor (NC), Ronnie P. Thomas (TN), Start Printed Page 56107William L. Thompson (MN), Juan Villanueva (TX), Robert D. Watts (TX), Cindy L. Wells (NY), Charles W. White (IN), Herman D. Whitehurst (AR), Kermit D. Williams (KY), Michael D. Worl (MT), Tommy W. Wornick (TX), Robert T. Yeftich (IN), Alan C. Yeomans (CT), Chad C. Yerkey (PA)

In accordance with 49 U.S.C. 31136(e) and 31315 each exemption is valid for two years unless revoked earlier by FMCSA. The exemption will be revoked if the following occurs: (1) The person fails to comply with the terms and conditions of the exemption; (2) the exemption has resulted in a lower level of safety than was maintained before I was granted; or (3) continuation of the exemption would not be consistent with the goals and objectives of 49 U.S.C. 31136(e) and 31315. If the exemption is still effective at the end of the 2-year period, the person may apply to FMCSA for a renewal under procedures in effect at that time.

Start Signature

Issued on: September 12, 2014.

Larry W. Minor,

Associate Administrator for Policy.

End Signature End Supplemental Information

[FR Doc. 2014-22257 Filed 9-17-14; 8:45 am]

BILLING CODE 4910-EX-P